LIVE
NIFTY 50—SENSEX—BANK NIFTY—FINNIFTY—INDIA VIX—NIFTY IT—NIFTY AUTO—NIFTY MID—GIFT NIFTY—USD/INR—NIFTY 50—SENSEX—BANK NIFTY—FINNIFTY—INDIA VIX—NIFTY IT—NIFTY AUTO—NIFTY MID—GIFT NIFTY—USD/INR—NIFTY 50—SENSEX—BANK NIFTY—FINNIFTY—INDIA VIX—NIFTY IT—NIFTY AUTO—NIFTY MID—GIFT NIFTY—USD/INR—
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

DRREDDY

NSEBSE
F&O
Dr. Reddy's Laboratories Limited
Healthcare· Pharmaceuticals & Biotechnology· INE089A01031· Scrip: 500124
ENहिन्दीગુજરાતીमराठी
₹૧,૩૧૧.૧૦
▲ 0.10 (+0.01%)
7/5/2026, 12:05:53 pm
NSE
₹૧,૩૧૧.૧૦
▲ ૦.૧૦
+૦.૦૧%
BSE
₹૧,૩૧૦.૫૦
▲ ૩૯.૫૫
+૦.૦૦%
1,1421,1991,2561,3131,37005-0707-0208-2910-2812-2402-2304-3005-06
૨૪૪ ટ્રેડિંગ દિવસ · 1Y સમયગાળો
આજ
ખૂલ્લ૧,૩૦૯.૧૦
ઊંચ૧,૩૧૫.૭૦
નીચ૧,૨૯૭.૩૦
અગાઉ બંધ૧,૩૧૧.૦૦
વૉલ્યુમ૧૬.૮૬L
મૂલ્ય₹૨૨૦.૫Cr
L: 1,297.30H: 1,315.70
52 સપ્તાહ
નીચ₹૧,૧૨૯.૪૦
ઊંચ₹૧,૩૭૯.૭૦
૭૩% 52 સપ્તાહ રેન્જમાં
માહિતી
અંકિત મૂલ્ય₹૧
સૂચિબદ્ધ2003-05-30
ISININE089A01031
SeriesA
BSE સ્ક્રિપ500124

મુખ્ય સૂચકો

1D
+3.14%
1W
-3.21%
1M
+8.39%
3M
+6.11%
6M
+2.48%
મૂલ્યાંકન
P/E (TTM)૨૫.૦૦
P/E (Qtr Ann.)૧૯.૩૧
P/Sales૩.૪૪
વૃદ્ધિ (ત્રિ.)
આવક+4.27%
PAT+4.64%
EPS+462.67%
નફાકારકતા
TTM EBITDA M.૨૮.૪%
TTM આવક
₹31229 Cr
TTM EBITDA
₹8877 Cr
TTM PAT
₹5448 Cr
TTM EPS
₹૫૨.૪૪

ત્રિમાસિક નાણાકીય

આવક
EBITDA
PAT
EPS
0 Cr2095 Cr4191 Cr6286 Cr8381 Cr22-1223-0323-0923-1224-0324-0624-0924-12₹15.0₹11.6₹17.8₹16.6₹15.7₹16.7₹3.0₹17.0
ત્રિમાસઆવકExpensesEBITDAPBTPATEPS
2024-12-318381 Cr6661 Cr2342 Cr1870 Cr1404 Cr₹16.97
2024-09-308038 Cr6434 Cr2308 Cr1911 Cr1342 Cr₹3.02
2024-06-307696 Cr6007 Cr2257 Cr1877 Cr1392 Cr₹16.72
2024-03-317114 Cr5710 Cr1969 Cr1602 Cr1310 Cr₹15.73
2023-12-317237 Cr5627 Cr2200 Cr1826 Cr1381 Cr₹16.59
2023-09-306903 Cr5305 Cr2288 Cr1913 Cr1482 Cr₹17.82
2023-03-316315 Cr5132 Cr1637 Cr1322 Cr960 Cr₹11.56
2022-12-316790 Cr5217 Cr1955 Cr1632 Cr1244 Cr₹14.98

શેરહોલ્ડિંગ પેટર્ન

વર્તમાન — 2026-03-31
26.6%પ્રમોટર
પ્રમોટર26.6%
FII33.1%
DII30.7%
સાર્વજનિક73.1%
પ્રમોટર હોલ્ડિંગ ટ્રેન્ડ
26.6%24-0626.6%24-0926.6%24-1226.6%25-0326.6%25-0926.6%25-1226.6%26-03

કોર્પોરેટ ક્રિયાઓ

એક્સ-તારીખપ્રકારહેતુ
2025-07-10DividendDividend - Rs 8 Per Share
2024-10-28SplitFace Value Split (Sub-Division) - From Rs 5/- Per Share To Re 1/- Per Share
2024-07-16DividendAnnual General Meeting/Dividend - Rs 40 Per Share
2023-07-11DividendAnnual General Meeting/Dividend - Rs 40 Per Share
2022-07-11DividendAnnual General Meeting/Dividend - Rs 30 Per Share
2021-07-09Dividend Annual General Meeting/Dividend - Rs 25 Per Share
2020-07-13Dividend Annual General Meeting/Dividend - Rs 25 Per Share
2019-07-15Dividend Annual General Meeting/Dividend - Rs 20 Per Share
2018-07-16Dividend Annual General Meeting/Dividend- Rs 20 Per Share
2017-07-17Dividend Annual General Meeting/Dividend - Rs 20/- Per Share
2016-07-18Dividend Annual General Meeting/ Dividend - Rs 20/- Per Share
2015-07-10DividendAnnual General Meeting/Dividend Rs 20/- Per Share
2014-07-11DividendAnnual General Meeting / Final Dividend - Rs 18/- Per Share
2013-07-12DividendAnnual General Meeting And Dividend Rs.15/- Per Share
2012-06-28DividendAnnual General Meeting And Dividend - Rs.13.75 Per Share
2011-06-30DividendAnnual General Meeting And Dividend Rs.11.25 Per Share
2011-03-17BonusScheme Of Arrangement - Bonus Debentures 6:1
2010-07-02DividendAnnual General Meeting And Final Dividend Rs.11.25 Per Share
2009-07-03OtherAgm/Div-Rs.6.25 Per Share
2008-07-04DividendAgm/Dividend - 75%

કમાણી ટ્રાન્સક્રિપ્ટ

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 24,...
24 Apr 2026NSE3K chars
Read →
Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Earnings call recordings'.
25 Oct 2025NSE1K chars
Read →
Dr. Reddy's Laboratories Limited has informed the Exchange about Investor Presentation
24 Oct 2025NSE17K chars
Read →
Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 1...
13 Oct 2025NSE3K chars
Read →
Dr. Reddy's Laboratories Limited has informed the Exchange about Investor Presentation
23 Jul 2025NSE12K chars
Read →
Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 15, ...
15 Jul 2025NSE3K chars
Read →
Dr. Reddy's Laboratories Limited has informed the Exchange about Investor Presentation
9 May 2025NSE14K chars
Read →
Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 24,...
24 Apr 2025NSE7K chars
Read →
Dr. Reddy's Laboratories Limited has informed the Exchange about Analyst/Investor Meet
17 Nov 2023NSE1K chars
Read →
Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript of Earnings call for Q1 ...
31 Jul 2023NSE49K chars
Read →
Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript of Analysts/Institutiona...
3 Nov 2022NSE46K chars
Read →
Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript of Analysts/Institutiona...
3 Aug 2022NSE1K chars
Read →
Dr. Reddy's Laboratories Limited has informed the Exchange about Audio Recordings of the Earnings ca...
29 Jul 2022NSE1K chars
Read →
Dr. Reddy's Laboratories Limited has informed the Exchange about Earnings Call for Q1 FY2023
13 Jul 2022NSE6K chars
Read →
Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript of Analysts/Institutiona...
28 Jun 2022NSE1K chars
Read →
Dr. Reddy's Laboratories Limited has informed the Exchange about Investor Presentation
21 Jun 2022NSE24K chars
Read →
Dr. Reddy's Laboratories Limited has informed the Exchange about transcript of earnings call held on...
24 May 2022NSE47K chars
Read →
Dr. Reddy's Laboratories Limited has informed the Exchange about Disclosure of presentation and the ...
20 May 2022NSE1K chars
Read →
Dr. Reddy's Laboratories Limited has informed the Exchange about Earnings call for Q4 and FY22
25 Apr 2022NSE6K chars
Read →
Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation on earnings call tr...
1 Feb 2022NSE43K chars
Read →

ભાવ ઇતિહાસ

તારીખખૂલ્લઊંચનીચબંધવૉલ્યુમ
2026-05-06૧,૨૮૨.૦૦૧,૩૨૮.૬૦૧,૨૭૭.૧૦૧,૩૧૧.૦૦૩૩.૪૦L
2026-05-05૧,૨૮૭.૬૦૧,૨૯૨.૪૦૧,૨૬૮.૫૦૧,૨૭૧.૨૦૯.૮૬L
2026-05-04૧,૩૨૦.૦૦૧,૩૨૦.૦૦૧,૨૮૦.૬૦૧,૨૮૭.૨૦૨૨.૮૬L
2026-04-30૧,૩૨૭.૦૦૧,૩૪૦.૩૦૧,૩૧૩.૬૦૧,૩૨૨.૯૦૧૨.૨૭L
2026-04-29૧,૩૬૭.૦૦૧,૩૭૫.૯૦૧,૩૨૧.૫૦૧,૩૨૯.૮૦૪૫.૪૬L
2026-04-28૧,૩૪૨.૪૦૧,૩૬૭.૯૦૧,૩૨૭.૪૦૧,૩૫૪.૬૦૨૩.૩૬L
2026-04-27૧,૩૨૦.૪૦૧,૩૫૦.૦૦૧,૩૦૯.૦૦૧,૩૩૪.૫૦૧૯.૪૦L
2026-04-24૧,૨૯૩.૦૦૧,૩૪૮.૮૦૧,૨૯૩.૦૦૧,૩૧૭.૧૦૫૬.૩૯L
2026-04-23૧,૨૩૦.૦૦૧,૩૫૭.૦૦૧,૨૧૭.૫૦૧,૩૩૧.૦૦૧.૬૪Cr
2026-04-22૧,૨૧૪.૧૦૧,૨૨૬.૦૦૧,૨૦૮.૧૦૧,૨૧૭.૦૦૧૫.૭૩L
2026-04-21૧,૨૩૨.૬૦૧,૨૩૪.૯૦૧,૨૧૮.૪૦૧,૨૨૦.૬૦૧૨.૩૧L
2026-04-20૧,૨૩૫.૦૦૧,૨૪૩.૦૦૧,૨૨૩.૦૦૧,૨૩૨.૬૦૧૬.૦૫L
2026-04-17૧,૨૧૫.૨૦૧,૨૪૨.૦૦૧,૨૧૨.૪૦૧,૨૩૫.૭૦૨૫.૬૪L
2026-04-16૧,૨૨૨.૦૦૧,૨૨૭.૬૦૧,૨૧૪.૧૦૧,૨૨૧.૪૦૨૦.૧૪L
2026-04-15૧,૨૨૦.૦૦૧,૨૨૨.૦૦૧,૧૯૫.૪૦૧,૨૧૭.૮૦૪૬.૯૩L
2026-04-13૧,૨૧૮.૦૦૧,૨૩૯.૧૦૧,૨૦૪.૦૦૧,૨૩૫.૯૦૧૪.૬૩L
2026-04-10૧,૨૧૨.૮૦૧,૨૩૬.૮૦૧,૨૦૮.૮૦૧,૨૩૨.૨૦૧૯.૩૧L
2026-04-09૧,૧૮૯.૦૦૧,૨૧૪.૭૦૧,૧૮૯.૦૦૧,૨૧૧.૯૦૨૭.૪૭L
2026-04-08૧,૨૧૦.૦૦૧,૨૧૯.૯૦૧,૧૮૫.૪૦૧,૧૯૧.૪૦૨૦.૬૩L
2026-04-07૧,૨૦૮.૦૦૧,૨૧૧.૦૦૧,૧૭૯.૦૦૧,૧૯૬.૧૦૨૩.૩૧L
2026-04-02૧,૧૮૭.૫૦૧,૨૨૨.૬૦૧,૧૬૭.૫૦૧,૨૧૭.૩૦૩૫.૬૧L
2026-04-01૧,૨૮૦.૦૦૧,૨૮૪.૮૦૧,૨૦૬.૧૦૧,૨૦૯.૬૦૨૨.૪૧L
2026-03-27૧,૨૯૭.૦૦૧,૩૦૨.૯૦૧,૨૭૮.૨૦૧,૨૮૧.૭૦૨૧.૬૫L
2026-03-25૧,૨૬૮.૯૦૧,૩૦૯.૦૦૧,૨૬૦.૧૦૧,૩૦૦.૭૦૧૫.૭૭L
2026-03-24૧,૨૬૭.૨૦૧,૨૭૯.૮૦૧,૨૪૮.૪૦૧,૨૫૯.૬૦૩૧.૬૬L
2026-03-20૧,૨૮૯.૦૦૧,૩૦૭.૫૦૧,૨૮૮.૨૦૧,૨૯૮.૯૦૩૩.૬૦L
2026-03-19૧,૨૭૮.૭૦૧,૨૮૬.૪૦૧,૨૬૬.૭૦૧,૨૭૪.૫૦૧૦.૩૫L
2026-03-18૧,૨૮૩.૮૦૧,૨૯૯.૩૦૧,૨૮૦.૧૦૧,૨૯૪.૮૦૮.૫૦L
2026-03-17૧,૨૭૯.૯૦૧,૨૯૧.૪૦૧,૨૬૫.૦૦૧,૨૮૩.૮૦૧૦.૦૪L
2026-03-16૧,૨૯૨.૧૦૧,૨૯૭.૦૦૧,૨૬૪.૦૦૧,૨૭૬.૯૦૧૨.૯૫L

વારંવાર પૂછાતા પ્રશ્નો

વિશે

ડૉ. રેડ્ડીઝ લેબોરેટરીઝ લિમિટેડ, NSE પર DRREDDY તરીકે સૂચિબદ્ધ છે, તે એક ભારતીય બહુરાષ્ટ્રીય ફાર્માસ્યુટિકલ કંપની છે જે જેનરિક અને સ્પેશિયાલિટી દવાઓની વિશાળ શ્રેણી વિકસાવે છે, તેનું ઉત્પાદન કરે છે અને તેનું માર્કેટિંગ કરે છે.

Advertisement
BOARD OF DIRECTORS
Meeting
Whole-time Director
Allan Grant Oberman
Independent Director
DEPARTED
Sanjiv Mehta
Independent Director
Sridar Iyengar
Independent Director
Alpna Hansraj Seth
Additional Director
Arun Madhavan Kumar
Additional Director
Claudio Albrecht
Additional Director
Pennv Wan
Additional Director
Shikha Sanjaya Sharma
Additional Director